Back to Legal & General Group Plc Legal & General Group Plc

CPRXCPRX
Showing 8 of 31 quarters

Position history for Legal & General Group PlcLegal & General Group Plc's holdings in CATALYST PHARMACEUTICALS INC

Legal & General Group Plc holds 275,513 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $8.7M as of 2026-Q2. The position was increased (+2.1% shares). CPRX represents 0.0% of Legal & General Group Plc's portfolio.

Current Value

$8.7M

Current Shares

275,513

Total Value Change

+$2.2M

Total Shares Change

-50,933

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
275,513
+2.1%
$8.7M0.0%$31.43
28
2026-Q1
Decreased
269,867
-65.2%
$6.7M0.0%$23.92
0
2025-Q4
Increased
776,172
+0.3%
$18.1M0.0%$23.29
28
2025-Q3
Increased
774,104
+16.6%
$15.2M0.0%$19.55
33
2025-Q2
Increased
663,595
+15.7%
$14.4M0.0%$21.78
32
2025-Q1
Increased
573,637
+66.5%
$13.9M0.0%$24.69
41
2024-Q4
Increased
344,623
+5.6%
$7.2M0.0%$21.07
29
2024-Q3
Increased
326,446
+6.9%
$6.5M0.0%$19.56
29

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used